Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
8.66
-0.09 (-1.03%)
Feb 11, 2026, 4:00 PM EST
Hunan Nucien Pharmaceutical Company Description
Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China.
The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields.
Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.
Hunan Nucien Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 319 |
| CEO | Shi Xi Zhang |
Contact Details
Address: Building 1-2 Guangzhou, 510100 China | |
| Phone | 86 20 3895 2000 |
| Website | nucien.com |
Stock Details
| Ticker Symbol | 688189 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Liang Li | Deputy GM and Chief Financial Officer |
| Xuan Li | Secretary of the Board |
| Shi Jian | Deputy General Manager |
| Shukao Liu | Deputy General Manager |
| Shi Xi Zhang | Vice Chairman and GM |
| Xiaoning Chen | Accounting Supervisor |